Johnson Johnson Aktie
136,04
EUR
+1,60
EUR
+1,19
%
155,15
USD
+0,22
USD
+0,14
%
nachbörslich
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Kursziele der Johnson Johnson-Aktie in
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 136,60 GBP | - |
| Bayer | 1 | 8 | 0 | 25,51 EUR | +2,97% |
| Beiersdorf AG | 8 | 1 | 2 | 141,44 EUR | +16,99% |
| BioNTech (ADRs) | 4 | 2 | 0 | 131,67 USD | +37,43% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Douglas | 3 | 1 | 0 | 15,62 EUR | +28,88% |
| Fresenius Medical Care (FMC) St. | 3 | 5 | 2 | 48,71 EUR | -2,66% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 49,00 EUR | +13,72% |
| GSK PLC Registered Shs | 2 | 5 | 1 | 16,30 GBP | +8,16% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 165,86 EUR | +42,61% |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +153,50% |
| MorphoSys | 0 | 0 | 0 | - | - |
| Nestlé SA (Nestle) | 3 | 7 | 1 | 85,67 CHF | -2,31% |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +6,08% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 28,80 USD | +22,61% |
| Procter & Gamble Co. | 1 | 0 | 0 | 177,00 USD | +4,19% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 115,12 EUR | +31,85% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Unilever plc | 6 | 1 | 3 | 47,11 GBP | +0,08% |
| Valneva | 0 | 0 | 0 | - | - |